Increased anxiety-related behavior in mice deficient for metabotropic glutamate 8 (mGlu8) receptor

Neuropharmacology

Volumn 43, Issue 2, 2002, Pages 251-259

  Linden, A M ^a   Johnson, B G ^a   Peters, S C ^a   Shannon, H E ^a   Tian, M ^a   Wang, Y ^a   Yu, J L ^a   Koster A ^a   Baez, M ^a   Schoepp, D D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Anxiety; Elevated plus maze; mGlu8 receptor deficient mice; Seizure susceptibility

Indexed keywords

METABOTROPIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FLUORESCENT LIGHTING; GENE DELETION; LOCOMOTION; MALE; MAZE TEST; MOTOR SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; STRAIN DIFFERENCE; STRESS;

ANIMALS; ANXIETY; FEMALE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 0036669732     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00079-5     Document Type: Article

References (34)

1. Adams, B., Fitch T., Chaney, S., Gerlai, R., 2002. Altered performance characterized in cognitive tasks: comparison of the albino ICR and CD1 mouse strains. Behavioral Brain Research, in press.
2. Andrews N., File S.E. Handling history of rats modifies behavioural effects of drugs in the elevated plus-maze test of anxiety. European Journal of Pharmacology. 235:1993;109-112.
3. Andrews N., Zharkovsky A., File S.E. Acute handling stress downregulates benzodiazepine receptors: reversal by diazepam. European Journal of Pharmacology. 210:1992;247-251.
4. Beck C.H.M., Fibiger H.C. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. The Journal of Neuroscience. 15:1995;709-720.
5. Beracochea D.J., Krazem A. Effects of mamillary body and mediodorsal thalamic lesions on elevated plus maze exploration. Neuroreport. 2:1991;793-796.
6. Bushell T.J., Jane D.E., Tse H.W., Watkins J.C., Garthwaite J., Collingridge G.L. Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices. British Journal of Pharmacology. 117:1996;1457-1462.
7. Cartmell J., Schoepp D.D. Regulation of neurotransmitter release by metabotropic glutamate receptors. Journal of Neurochemistry. 75:2000;889-907.
8. Chowdhury G.M.I., Fujioka T., Nakamura S. Induction and adaptation of Fos expression in the rat brain by two types of acute restraint stress. Brain Research Bulletin. 52:2000;171-182.
9. Conn P.J., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Annual Review of Pharmacology and Toxicology. 37:1997;205-237.
10. Corti C., Restituito S., Rimland J.M., Brabet I., Corsi M., Pin J.P., Ferraguti F. Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8. European Journal of Neuroscience. 10:1998;3629-3641.
11. Duvoisin R.M., Zhang C., Ramonell K. A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb. Journal of Neuroscience. 15:1995;3075-3083.
12. Ferris P., Seward E., Dawson G.R. Interactions between LY354740, a group II metabotropic agonist and the GABAA-benzodiazepine receptor complex in the rat elevated plus maze. Journal of Psychopharmacology. 15:2001;76-82.
13. File, S.E., Andrews, N., Wu, P.Y., Zharkovsky, A., Zangrossi Jr, H., 1992. Modification of chlordiazepozide's behavioural and neurochemical effects by handling and plus-maze experience. European Journal of Phamacology 218, 9-14.
14. Graeff F.G., Silveira M.C.L., Nogueira R.L., Audi E.A., Oliveira R.M.W. Role of the anygdala and periaqueductal gray in anxiety and panic. Behavioural Brain Research. 58:1993;123-131.
15. Helton D.R., Tizzano J.P., Monn J.A., Schoepp D.D., Kallman M.J. Anxiolytic and side-effect profile of LY354740: a potent, highly selective, orally active agonist for group III metabotropic glutamate receptors. Journal of Pharmacology and Experimental Therapeutics. 284:1998;651-660.
16. Hinks G.L., Brown P., Field M., Poat J.A., Hughes J. The anxiolytics CI-988 and chlordiazepoxide fail to reduce immediate early gene mRNA stimulation following exposure to the rat elevated X-maze. European Journal of Pharmacology. 312:1996;153-161.
17. Hogg S. A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacology Biochemistry and Behavior. 54:1996;21-30.
18. Irwin S. Comprehensive observational assessment: IA. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia. 13:1968;222-257.
19. Kinoshita A., Ohishi H., Neki A., Nomura S., Shigemoto R., Takada M., Nakanishi S., Mizuno N. Presynaptic localization of a metabotropic glutamate receptor, mGluR8, in the rhinencephalic areas: a light and electron microscopy study in the rat. Neuroscience Letters. 207:1996;61-64.
20. Klapstein G.J., Meldrum B.S., Mody I. Decreased sensitivity to group III mGluR agonists in the lateral perforant path following kindling. Neuropharmacology. 38:1999;927-933.
21. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology. 92:1987;180-185.
22. Malherbe P., Kratzeisen C., Lundstrom K., Richards J.G., Faull R.L., Mutel V. Cloning and functional expression of alternative splice variants of the human metabotropic glutamate receptor 8. Brain Research Molecular Brain Research. 67:1999;201-210.
23. Moldrich R.X., Beart P.M., Jane D.E., Chapman A.G., Meldrum B.S. Anticonvulsant activity of 3,4-dicarboxyphenylglycines in DBA/2 mice. Neuropharmacology. 40:2001;732-735.
24. Sapolsky R.M. Do glucocorticoid concentrations rise with age in the rat. Neurobiology of Aging. 13:1992;171-174.
25. Saugstad J.A., Kinzie J.M., Shinohara M.M., Segerson T.P., Westbrook G.L. Cloning and expression of rat metabotropic glutamate receptor 8 reveals a distinct pharmacological profile. Molecular Pharmacology. 51:1997;119-125.
26. Scanziani M., Salin P.A., Vogt K.E., Malenka R.C., Nicoll R.A. Use-dependent increases in glutamate concentration activate presynaptic metabotropic glutamate receptors. Nature. 385:1997;630-634.
27. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. Journal of Pharmacology and Experimental Therapeutics. 299:2001;12-20.
28. Schoepp D.D., Jane D.E., Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology. 38:1999;1431-1476.
29. Shigemoto R., Kinoshita A., Wada E., Nomura S., Ohishi H., Takada M., Flor P.J., Neki A., Abe T., Nakanishi S., Mizuno N. Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. Journal of Neuroscience. 17:1997;7503-7522.
30. Spooren W.P.J.M., Schoeffter P., Gasparini F., Kuhn R., Gentasch C. Pharmacological and endocrinological characterization of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). European Journal of Pharmacology. 435:2002;161-170.
31. Stone E.A., Zhang Y. Adrenoceptor antagonists block c-fos response to stress in the mouse brain. Brain Research. 694:1995;279-286.
32. Thomas N.K., Wright R.A., Howson P.A., Kingston A.E., Schoepp D.D., Jane D.E. (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal spinal cord. Neuropharmacology. 40:2001;311-318.
33. Yokoi M., Kobayashi K., Manabe T., Takahashi T., Sakaguchi I., Katsuura G., Shigemoto R., Ohishi H., Nomura S., Nakamura K., Nakao K., Katsuki M., Nakanishi S. Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2. Science. 273:1996;645-647.
34. Zhai, J., Tian, M.T., Wang, Y., Yu, J.L., Koster, A., Baez, M., Nisenbaum, E.S., 2002. Modulation of lateral perforant path excitatory response in mGlu8 receptors. Neuropharmacology 43, this issue, PII: S0028-3908(02)00087-4.